| Authors: |
Cirrincione AM; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Bärtsch MA; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., John L; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Reichert P; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Huhn S; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Blaney P; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Gagler D; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Davies F; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Weisel KC; Department of Oncology, Hematology, and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Morgan GJ; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL. |
